5-carboxamidotryptamine has been researched along with Nervous System Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edvinsson, L; Larsen, CC; Povlsen, GK; Rasmussen, MN | 1 |
1 other study(ies) available for 5-carboxamidotryptamine and Nervous System Diseases
| Article | Year |
|---|---|
Improvement in neurological outcome and abolition of cerebrovascular endothelin B and 5-hydroxytryptamine 1B receptor upregulation through mitogen-activated protein kinase kinase 1/2 inhibition after subarachnoid hemorrhage in rats.
Topics: Animals; Behavior, Animal; Butadienes; Cerebral Arteries; Endothelin B Receptor Antagonists; Immunohistochemistry; Male; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Muscle Contraction; Muscle, Smooth, Vascular; Nervous System Diseases; Nitriles; Postural Balance; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Subarachnoid Hemorrhage; Up-Regulation; Vasoconstriction | 2011 |